Click the star to add/remove an item to/from your individual schedule.
You need to be logged in to avail of this functionality.
Log in
- Convenors:
-
Violeta Argudo-Portal
(Universitat de Barcelona)
Masha Denisova (Maastricht University)
Send message to Convenors
- Format:
- Combined Format Open Panel
Short Abstract:
This panel seeks to make explicit the contributions of STS to the study of cancer. We invite empirical and theoretical contributions that revolve around the study of cancer. Works exploring carcinogenic leaks, cancer politics, and epistemic absences are particularly welcome.
Long Abstract:
The study of cancer has gathered an extensive community of scholars in the social sciences and humanities, providing a more dense, heterogeneous, and diverse approach to this disease multiple. Science and technology scholars have taken an important role in this task by examining how knowledge about cancer is produced and with what consequences for researchers, practitioners, and patients. In this panel, we seek to make explicit the contributions of STS tools and sensibilities to the cancer study. STS toolkit becomes particularly helpful in discerning what logics, interests, and imaginaries are at play in the cancer research and care arena. The ever-increasing influence of pharmaceutical companies and investments in heavily technocratic forms of cancer care transform not only the forms of cancer diagnostics and treatment but also the experiences of those living with the disease. The growing attention to cell biology research and individualization of risk makes cancer research shift further from identifying other aetiologies of cancer, such as environmental and ecological links. These transformations collectively shape how cancer is known and lived with. For this panel, we invite empirical and theoretical submissions that revolve around the study of cancer, ranging from attention to high-tech technological and pharmaceutical endeavors to different forms of crafting care, knowledge, treatments, infrastructures, and knowledge. Works exploring carcinogenic leaks, cancer politics, and epistemic absences are particularly welcome.
The panel is convened by the Political Stakes of Cancer Network, an international group of social sciences and humanities scholars studying science, society, and power relationships in cancer across the globe. The panel will follow a combined format, including sessions with conventional paper presentations and an experimental session for which we encourage submissions based on multimodal materials (illustrations, short films, visual essays, experimental data visualizations, and more).
Accepted contributions:
Session 1Jennifer Fraser (King's College London)
Short abstract:
To show how past and present means of ‘building cancer worlds’ are based on negotiated understandings of facts and forms this presentation traces the historical evolution of global cancer atlases from the early twentieth century to the present day.
Long abstract:
In 2019, the International Union Against Cancer, in partnership with the American Cancer Society and International Agency for Research on Cancer, launched “The Cancer Atlas”—a visual and comprehensive overview of cancer worldwide. Aimed at a broad readership, the Atlas serves as an authoritative set of knowledge about the global cancer burden. By providing a global compendium of disease, it provides governments, public health agencies, policymakers, patients, and the general public with a reliable base for evidence-based decision making. When the Atlas was launched it was heralded as a powerful new policy, and public education tool. Indeed, many experts believed that presenting cancer data in an easy-to-consume, interactive fashion would democratize cancer data, cultivate partnerships, and inspire collective against the disease worldwide. Despite its accessible nature and user-friendly format, the image of the world that the Cancer Atlas projects is not as simple and straightforward as the compendium’s communications team would have us believe. Cancer atlases rely on a vast research infrastructure, a web of national and international relations, hours of labour, and dizzying array of theoretical and methodological considerations and collective imaginings about what the global cancer burden is and how it should be represented. To show how past and present means of ‘building cancer worlds’ (Masco, 2021) are based on “negotiated understandings of facts and forms,” often for the purpose of creating “collective thought-styles to promote consensual ways of seeing,” (Fleck, 1981) this presentation traces the historical evolution of global cancer atlases from the early twentieth century to the present day. By tracing these compendiums through their many iterations and origins, from medical geography and geographic pathology in the 1930s and 1950s, to global geocancerology and cancer epidemiology in the 1980s and 2000s, I show how efforts to view cancer from “outside and above” (Struck, 2014) are rooted in their own spatial and temporal configurations, and that while these resources often project authoritative images of scientific objectivity, the cancer stories they tell are actually highly curated collections of valued and validated knowledge.
References:
Fleck, Ludwik. Genesis and Development of a Scientific Fact (Chicago: University of Chicago Press, 1981), 161.
Masco, Joseph. The Future of Fallout, and Other Episodes in Radioactive World-Making. Durham: Duke University Press, 2021.
Struck, Wolfgang. “Genesis, Retold: In Search of an Atlas of the Anthropocene.” Environmental Humanities 5 (2014): 217-232.
Thandeka Cochrane (King's College London) David Reubi (King's College London)
Short abstract:
This paper explores how the African Cancer Registry Network tries to incorporate questions of knowledge, data justice and equity in global cancer data relations and attempts to redress global inequalities by creating pan-African solidarities, local expertise and networked knowledge communities.
Long abstract:
Cancer is perhaps one of the most data heavy contemporary disease categories. Dependent on vast quantities of data for treatment paths, infrastructure building and even aetiological causes, extensive amounts of cancer data are produced by most countries across this world. This data, which gives information such as the top cancers in a country, forms the backbone of contemporary cancer policies. Recognising the importance of this data, many countries across the world have set up cancer registries, expressly for the purpose of producing cancer data. Much of this data is centrally collected, audited and analysed by the International Agency for Research on Cancer (IARC), a WHO body. Africa, however, has a long history of severe paucity in cancer data. Long not considered a disease of concern on a continent marked by infectious diseases, systems and structures for the production of cancer data on the continent have continuously struggled to stay alive. In this paper, we examine a little known network which is attempting to address the vast cancer data inequity on the continent: the African Cancer Registry Network. Established in 2012 on the ruins of earlier colonial efforts to measure and map cancer in Africa, the AFCRN works on a range of epidemiological surveillance efforts on the continent in partnership with the IARC as well as with Western universities, African governments, cancer charities and the pharmaceutical industry. Besides playing a critical role in the making of the Africa-section of IARC’s famous Global Cancer Maps (GloboCan), the network has also participated in many epidemiological cancer studies that seek to ascertain where best to invest resources and what type of interventions work.
This paper explores how the network tries to incorporate questions of knowledge, data justice and equity in global data relations. Indeed, a certain notion of justice was one of the main rationales for the establishment of the network. Specifically, by creating the network, the founders hoped to give Africans more control over the collection, analysis and use of cancer data from the continent, seeking rebuild data production capacities on the continent through cross-continental collaborations, by foregrounding African registrars and registries capacities and building local expertise. We explore these ethical hopes and how the network’s founders sought to operationalise them through a range of strategies, from training opportunities to creating a sense of community to data sharing protocols. While many of the founders’ efforts have been successful, some old inequalities and injustices have persisted, and new ones have come to the fore. We examine some of these injustices like the persistent lack of funding or the way low-skilled Africa data collectors feels themselves exploited by better educated and connected African medical researchers. In the face of economic, structural and epistemic inequalities in the collection of cancer data in Africa, this paper examines the AFRCN as an attempt to redress these inequalities through the creation of pan-African solidarities, local expertise and networked knowledge communities.
Nick Surawy Stepney (King's College London)
Short abstract:
Cancer epidemiology is rarely neutral in its practice. This paper examines the development, techniques and methods of the network of cancer registries in India, probing its political stakes, asking how it spatialises the disease, and what its mode of data generation obscures and reveals.
Long abstract:
Cancer registration is a scientific endeavour that aims to systematically generate knowledge on the incidence and prevalence of the disease in given populations, establish regional disease burdens, and subsequently undergird health policies that aim to address imbalances in access to care and interventions such as screening. Yet STS scholarship has demonstrated that such epidemiological endeavours are seldom simply the neutral collection and collation of data they are often assumed, be it the inherited logics they employ, or in the construction of disease objects or populations they purport only to study. Data is political. Cancer framed as an ‘epidemic’ secures funding, the rise of fall of individual cancer types allows claims to be made about relative levels of ‘development’ and the successes or failures of political projects. In this paper I analyse the cancer registry system in India, asking how, since its inception in the early 1980s, this network has developed, how the forms of research it undertakes have shifted, what its mode of data generation can reveal and obscure, and how this data is utilised in the spatialisation of cancer risk across the country. Narratives of ‘transition’ describe changes in diet, family structure, lifestyle, demographic makeup, and disease patterns (typically linking the rise particularly of colorectal cancers with a move towards ‘affluent’ lifestyles), yet are belied by the means of data collection and the populations that they cover. In this paper therefore, I examine the stakes of this data collection and the imaginaries and techniques it employs.
Anna Dowrick (University of Oxford)
Short abstract:
This paper draws attention to the absence of cancer, exploring how negative diagnoses are figured in planning of cancer pathways and patient stories of ‘all-clear’ results. This contributes to thinking about how the anticipation of ‘not cancer’ is mobilised as part of imaginaries of cancer futures.
Long abstract:
National and international policy focus on cancer control has both prolonged life with cancer and altered the temporality of life at risk of cancer (Manderson, 2015, Andersen 2023). While this can foreground the potential presence of cancer, imagining the absence of cancer plays an equally important role in cancer detection initiatives, in that all-clear or indeterminate results create different responsibilities for health services in offering reassurance and closure.
This paper draws attention to the absence of cancer, drawing on two cases which emphasise different moments in the cancer detection journey. First, exploring the beginning of processes of cancer identification, I examine the mobilisation of professional and institutional resources during current efforts in the UK to improve colorectal cancer diagnosis. In exploring efforts to find more cases of cancer, I pay particular attention to how those who are anticipated not to have cancer are figured in planning. Second, looking at the endpoint of cancer detection pathways, I share insights from patients who have received an ‘all-clear’ after passing through novel pathways for vague symptoms.
Contrasting how the ‘absent presence’ of cancer is manifest in both cases, I further thinking on the flows of anticipation (Clarke, 2015) that shape cancer detection efforts, particularly how this relates to the concept of ‘chronic living’ (Heinsen, Wahlberg, Petersen, 2021). Through this I aim to contribute to STS conversations about how imaginaries of futures with and without cancer are mobilised in everyday life.
Natalia Luxardo (University of Buenos Aires)
Long abstract:
Examining cancer inequalities poses epistemological challenges, and many disciplines provide hypothesis to explain them. In the last decades, anthropology, and other social sciences address that more than fragmented “variables”, social inequalities operate through overlapping and complex routes spanning multiple levels. This study shed light on socioeconomic and cultural pathways that shape conditions for the emergence of inequalities in the cancer care and control continuum. We include some of the diverse multiethnic, unequal and heterogeneous subpopulations of Argentina. The research is based on a collaborative ethnography in combination with audiovisual methods. Three communities were selected: 1) rural workers; 2) artisanal fishermen and 3) waste-pickers. The results show routes shaped by historical systematic patterns, crossing multiple levels and contexts. They include the accumulation of ecological hazards and environmental exposures across the lifecourse, infrastructure of segregated neighborhoods, ways of lives shaped by cumulative experiences of material and symbolic deprivations and suffering in contexts of traditional rigid gender roles (e.g., men rejecting prevention and early detection programs, such as colorectal screenings). Also, systemic barriers and deterrents of the public healthcare institutions, including staff stereotyping and racism. Communitarian forces ameliorate them, such as deep social connections . The study concludes that underserved communities are less likely to benefit from cancer advances and are at higher risk of risks, through pathways of social inequalities expressed in systematic disadvantages. Reducing them needs of conceptually-driven frameworks that connect levels and data. Anthropological theories are essential in this vein, moving causation debates upstream, and expanding cancer control incumbencies.
Megan Cogburn (University of Florida) Mohamed Rafiq (New York University)
Long abstract:
Today in Tanzania the National Cancer Control Strategy estimates that only 10% of cancer cases reach the referral level and over 80% of these cases arrive in late stages. [Tanzania National Control Strategy estimates]. In this context of palliation as care, cancer becomes a lens to observe various layers of epistemic absences and how they unfold at various scales or social contexts. These absences in Tanzania entail not only the lack of diagnostic and therapeutic technologies and medicines but also extend to gaps in the knowledge and understanding of the roles and experiences of health providers, traditional and spiritual healers. Based on ethnographic data conducted at a national cancer hospital in Dar es Salaam and communities in Bagamoyo, Tanzania in 2021 and 2024, this paper explores epistemic absence by focusing on the experiences of providers, their intermediaries, and patients. We ask, how do health workers, patients, and family members make do, talk about, and experience cancer? How do political, technological, and sociocultural silences surrounding cancer shape what practices count as care, and in turn how do existing care practices inside and outside of biomedical health facilities shape local lexicons and possibilities for cancer prevention and treatment? In what ways is cancer rendered as biomedical, social, and technological? Where and how can cancer be treated in individual bodies, communities, and environments? We seek to transform the study of cancer in Tanzania by centering these epistemic absences, their imaginaries and limitations, asking what is at stake if they are not urgently addressed.
Ayush Shukla (Athena Institute, VU Amsterdam) Michiel Van Oudheusden (VU Amsterdam) Victor Avramov (Vrije Universiteit Amsterdam)
Long abstract:
Metastatic melanoma is considered hard to treat and worrisome skin cancer. A limited efficacy of existing therapies for its treatment has motivated researchers in the MELOMANES project to develop an “innovative immunotherapy treatment enhanced by nanoparticles”. Beyond the molecular complexity that needs to be addressed, skin cancers as complex societal problems warrant additional perspectives from health systems, public and environmental health domains as well as lived experiences of patients. Furthermore, the development and purchase of treatments for skin cancers is becoming increasingly expensive, and access to such treatments is far from universally guaranteed. Such aspects of treating skin cancer are often ignored in the biomedical literature alone, despite the usefulness of biomedical interventions being dependent on their distribution, development, pricing, and prevention efforts. In short, the biomedical problematization of and solutions to skin cancers are stealthily intertwined with multiple disciplines and with multiple public health and political economy aspects of treating skin cancers. Using metastatic melanoma as a case study, we investigate a range of problem frames used in the literature (e.g. biomedicine, public health, political economy) and by the experts to describe the problems and the challenges of treating metastatic melanoma. Building upon our engagement as integrated STS researchers in the EC funded project MELOMANES, we explore how these frames can be aligned into a transdisciplinary problem framing of skin cancer treatment that can serve as a framework for reflexive evaluation of innovative treatments aimed at addressing a complex, interrelated societal problem.
Nina Morena (McGill University)
Long abstract:
On TikTok, young people with metastatic breast cancer (MBC) chronicle their experiences of living with their disease in videos that explain what is currently happening with their treatment. These “health update” videos keep their followers informed on a range of health-related phenomena.
Young folks with MBC reorient the conventions of social media updates to TikTok, modeling TikTok as a key part of accounting for and processing their experiences of chronic illness, in ways which go beyond representations of MBC. Considering the significance of social media use and storytelling within MBC research (Jacobson 2018, Mazza et al. 2022), I understand the processes of maintaining accounts centered around health updates to be evidence of feminist practices as described by feminist scholarship on women’s and young people’s ways of knowing as patients (Lorde 1979, Ehrenreich and English 1974).
These TikToks act as compelling evidence of the urgent need for advocacy and policy change, especially regarding new and more effective lines of treatment, as well as forms of feminist documentation and accounting of stories which are often excluded from public breast cancer messaging. I examine MBC health updates posted by young people on TikTok, and ask, what are the patterns and trends which characterize MBC update videos? What forms of media accounting (Humphreys 2018) do their creators adopt to not only self-disclose their diagnosis, but to explain its meaning and treatment trajectory? How do young people with MBC use TikTok to transform the genre of the health update?
(Contribution for 12-15 minute academic presentation.)